HomeHeadlinesTakeda Pharmaceutical (4502 JT) 2025/26 (JPY): Revenue 4.51tln (prev. 4.6tln Y/Y), Net -152.4bln (prev. +107.9bln Y/Y), Operating profit 6.22bln (prev. 342.6bln Y/Y)JUNE 5, 2026 AT 06:31 AMTakeda Pharmaceutical (4502 JT) 2025/26 (JPY): Revenue 4.51tln (prev. 4.6tln Y/Y), Net -152.4bln (prev. +107.9bln Y/Y), Operating profit 6.22bln (prev. 342.6bln Y/Y)ByNewsquawk StaffTrade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.Open Dashboard#TAKEDA PHARMACEUTICAL CO LTD#4502.JT#EU SESSION#JPY#ASIAN EQUITIES
JUNE 5, 2026 AT 06:31 AMTakeda Pharmaceutical (4502 JT) 2025/26 (JPY): Revenue 4.51tln (prev. 4.6tln Y/Y), Net -152.4bln (prev. +107.9bln Y/Y), Operating profit 6.22bln (prev. 342.6bln Y/Y)ByNewsquawk StaffTrade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.Open Dashboard#TAKEDA PHARMACEUTICAL CO LTD#4502.JT#EU SESSION#JPY#ASIAN EQUITIES